25 XP   0   0   10

Resmed Inc DRC
Buy, Hold or Sell?

Let's analyse Resmed together

PenkeI guess you are interested in Resmed Inc DRC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Resmed Inc DRC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Resmed Inc DRC

I send you an email if I find something interesting about Resmed Inc DRC.

Quick analysis of Resmed (30 sec.)










What can you expect buying and holding a share of Resmed? (30 sec.)

How much money do you get?

How much money do you get?
A$0.12
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$4.74
Expected worth in 1 year
A$5.52
How sure are you?
89.3%

+ What do you gain per year?

Total Gains per Share
A$0.97
Return On Investment
3.3%

For what price can you sell your share?

Current Price per Share
A$28.88
Expected price per share
A$26.64 - A$30.81
How sure are you?
50%

1. Valuation of Resmed (5 min.)




Live pricePrice per Share (EOD)

A$28.88

Intrinsic Value Per Share

A$6.31 - A$7.45

Total Value Per Share

A$11.06 - A$12.20

2. Growth of Resmed (5 min.)




Is Resmed growing?

Current yearPrevious yearGrowGrow %
How rich?$4.4b$3.4b$707.2m16.9%

How much money is Resmed making?

Current yearPrevious yearGrowGrow %
Making money$142.5m$141.6m$945.8k0.7%
Net Profit Margin19.8%23.0%--

How much money comes from the company's main activities?

3. Financial Health of Resmed (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#13 / 171

Most Revenue
#21 / 171

Most Profit
#13 / 171

What can you expect buying and holding a share of Resmed? (5 min.)

Welcome investor! Resmed's management wants to use your money to grow the business. In return you get a share of Resmed.

What can you expect buying and holding a share of Resmed?

First you should know what it really means to hold a share of Resmed. And how you can make/lose money.

Speculation

The Price per Share of Resmed is A$28.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Resmed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Resmed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$4.74. Based on the TTM, the Book Value Change Per Share is A$0.20 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Resmed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.090.3%0.100.3%0.090.3%0.070.3%0.060.2%
Usd Book Value Change Per Share0.150.5%0.130.4%0.100.3%0.090.3%0.110.4%
Usd Dividend Per Share0.030.1%0.030.1%0.030.1%0.030.1%0.030.1%
Usd Total Gains Per Share0.180.6%0.150.5%0.130.4%0.120.4%0.140.5%
Usd Price Per Share16.29-18.29-20.48-17.61-14.83-
Price to Earnings Ratio44.94-47.13-58.58-48.47-60.85-
Price-to-Total Gains Ratio91.23-119.36-309.00-176.70-318.39-
Price to Book Ratio5.37-6.47-8.66-8.64-7.86-
Price-to-Total Gains Ratio91.23-119.36-309.00-176.70-318.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.494752
Number of shares54
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.03
Usd Book Value Change Per Share0.130.09
Usd Total Gains Per Share0.150.12
Gains per Quarter (54 shares)8.366.48
Gains per Year (54 shares)33.4325.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16272371916
2135456133842
3198189205868
425108122277794
5321351553396120
63816218840115146
74419022147135172
85121725453154198
95724428760173224
106327132067192250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%27.01.00.096.4%27.01.00.096.4%
Book Value Change Per Share4.00.00.0100.0%10.01.01.083.3%17.02.01.085.0%21.06.01.075.0%21.06.01.075.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%28.00.00.0100.0%28.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%25.03.00.089.3%25.03.00.089.3%

Fundamentals of Resmed

About Resmed Inc DRC

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-04 23:57:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Resmed Inc DRC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Resmed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 18.0% means that $0.18 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Resmed Inc DRC:

  • The MRQ is 18.0%. The company is making a huge profit. +2
  • The TTM is 19.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.0%TTM19.8%-1.8%
TTM19.8%YOY23.0%-3.2%
TTM19.8%5Y19.2%+0.6%
5Y19.2%10Y18.2%+1.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ18.0%6.3%+11.7%
TTM19.8%6.5%+13.3%
YOY23.0%8.2%+14.8%
5Y19.2%7.3%+11.9%
10Y18.2%7.6%+10.6%
1.1.2. Return on Assets

Shows how efficient Resmed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • 1.9% Return on Assets means that Resmed generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Resmed Inc DRC:

  • The MRQ is 1.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.9%TTM2.1%-0.2%
TTM2.1%YOY2.6%-0.5%
TTM2.1%5Y2.1%0.0%
5Y2.1%10Y2.0%+0.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%1.3%+0.6%
TTM2.1%1.4%+0.7%
YOY2.6%2.0%+0.6%
5Y2.1%2.2%-0.1%
10Y2.0%2.0%+0.0%
1.1.3. Return on Equity

Shows how efficient Resmed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • 3.0% Return on Equity means Resmed generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Resmed Inc DRC:

  • The MRQ is 3.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.0%TTM3.4%-0.4%
TTM3.4%YOY4.1%-0.7%
TTM3.4%5Y3.6%-0.2%
5Y3.6%10Y3.4%+0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0%2.6%+0.4%
TTM3.4%2.9%+0.5%
YOY4.1%3.9%+0.2%
5Y3.6%3.9%-0.3%
10Y3.4%4.0%-0.6%

1.2. Operating Efficiency of Resmed Inc DRC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Resmed is operating .

  • Measures how much profit Resmed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 34.7% means the company generated $0.35  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Resmed Inc DRC:

  • The MRQ is 34.7%. The company is operating very efficient. +2
  • The TTM is 21.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ34.7%TTM21.5%+13.2%
TTM21.5%YOY28.7%-7.2%
TTM21.5%5Y27.3%-5.8%
5Y27.3%10Y26.2%+1.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ34.7%7.9%+26.8%
TTM21.5%7.6%+13.9%
YOY28.7%11.4%+17.3%
5Y27.3%10.2%+17.1%
10Y26.2%10.7%+15.5%
1.2.2. Operating Ratio

Measures how efficient Resmed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.71 means that the operating costs are $0.71 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.708. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.844. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.708TTM0.844-0.136
TTM0.844YOY0.715+0.129
TTM0.8445Y1.002-0.158
5Y1.00210Y1.038-0.036
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7081.133-0.425
TTM0.8441.124-0.280
YOY0.7151.082-0.367
5Y1.0021.101-0.099
10Y1.0381.056-0.018

1.3. Liquidity of Resmed Inc DRC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Resmed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 3.11 means the company has $3.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Resmed Inc DRC:

  • The MRQ is 3.112. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.073. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.112TTM3.073+0.039
TTM3.073YOY2.962+0.111
TTM3.0735Y2.602+0.471
5Y2.60210Y2.785-0.183
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1122.320+0.792
TTM3.0732.382+0.691
YOY2.9622.575+0.387
5Y2.6022.627-0.025
10Y2.7852.623+0.162
1.3.2. Quick Ratio

Measures if Resmed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.24 means the company can pay off $1.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Resmed Inc DRC:

  • The MRQ is 1.240. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.229. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.240TTM1.229+0.011
TTM1.229YOY1.226+0.003
TTM1.2295Y1.272-0.043
5Y1.27210Y1.207+0.065
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2401.111+0.129
TTM1.2291.137+0.092
YOY1.2261.286-0.060
5Y1.2721.423-0.151
10Y1.2071.521-0.314

1.4. Solvency of Resmed Inc DRC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Resmed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Resmed to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.35 means that Resmed assets are financed with 35.1% credit (debt) and the remaining percentage (100% - 35.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.351. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.381. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.351TTM0.381-0.030
TTM0.381YOY0.364+0.017
TTM0.3815Y0.410-0.029
5Y0.41010Y0.413-0.003
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3510.3510.000
TTM0.3810.357+0.024
YOY0.3640.357+0.007
5Y0.4100.359+0.051
10Y0.4130.371+0.042
1.4.2. Debt to Equity Ratio

Measures if Resmed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 54.1% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.541. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.617. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.541TTM0.617-0.077
TTM0.617YOY0.580+0.038
TTM0.6175Y0.712-0.095
5Y0.71210Y0.718-0.006
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5410.5410.000
TTM0.6170.559+0.058
YOY0.5800.545+0.035
5Y0.7120.610+0.102
10Y0.7180.669+0.049

2. Market Valuation of Resmed Inc DRC

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Resmed generates.

  • Above 15 is considered overpriced but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 44.94 means the investor is paying $44.94 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Resmed Inc DRC:

  • The EOD is 51.019. Based on the earnings, the company is expensive. -2
  • The MRQ is 44.942. Based on the earnings, the company is overpriced. -1
  • The TTM is 47.132. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD51.019MRQ44.942+6.077
MRQ44.942TTM47.132-2.190
TTM47.132YOY58.580-11.448
TTM47.1325Y48.471-1.340
5Y48.47110Y60.852-12.381
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD51.01914.638+36.381
MRQ44.94217.745+27.197
TTM47.13218.883+28.249
YOY58.58022.272+36.308
5Y48.47120.830+27.641
10Y60.85225.069+35.783
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Resmed Inc DRC:

  • The EOD is 42.907. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 37.796. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 45.389. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD42.907MRQ37.796+5.111
MRQ37.796TTM45.389-7.592
TTM45.389YOY575.509-530.120
TTM45.3895Y137.788-92.399
5Y137.78810Y98.420+39.368
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD42.90710.196+32.711
MRQ37.79610.068+27.728
TTM45.3891.502+43.887
YOY575.5093.822+571.687
5Y137.7887.817+129.971
10Y98.4200.759+97.661
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Resmed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 5.37 means the investor is paying $5.37 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Resmed Inc DRC:

  • The EOD is 6.091. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.365. Based on the equity, the company is overpriced. -1
  • The TTM is 6.471. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.091MRQ5.365+0.725
MRQ5.365TTM6.471-1.106
TTM6.471YOY8.656-2.186
TTM6.4715Y8.644-2.173
5Y8.64410Y7.861+0.783
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD6.0912.427+3.664
MRQ5.3652.782+2.583
TTM6.4712.828+3.643
YOY8.6563.290+5.366
5Y8.6443.530+5.114
10Y7.8614.227+3.634
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Resmed Inc DRC.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Resmed Inc DRC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2310.196+18%0.155+49%0.139+66%0.169+36%
Book Value Per Share--4.7424.447+7%3.702+28%3.250+46%2.919+62%
Current Ratio--3.1123.073+1%2.962+5%2.602+20%2.785+12%
Debt To Asset Ratio--0.3510.381-8%0.364-3%0.410-14%0.413-15%
Debt To Equity Ratio--0.5410.617-12%0.580-7%0.712-24%0.718-25%
Dividend Per Share--0.0480.046+4%0.043+11%0.048-1%0.044+9%
Eps--0.1420.151-6%0.137+3%0.115+23%0.100+42%
Free Cash Flow Per Share--0.1680.160+5%0.029+488%0.099+70%0.099+70%
Free Cash Flow To Equity Per Share--0.0060.015-57%0.182-97%0.054-88%0.054-88%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7.454--------
Intrinsic Value_10Y_min--6.315--------
Intrinsic Value_1Y_max--0.410--------
Intrinsic Value_1Y_min--0.403--------
Intrinsic Value_3Y_max--1.489--------
Intrinsic Value_3Y_min--1.416--------
Intrinsic Value_5Y_max--2.877--------
Intrinsic Value_5Y_min--2.649--------
Market Cap42479302737.920+12%37535448000.00042100539880.600-11%47063424520.320-20%40465377063.992-7%34117761716.486+10%
Net Profit Margin--0.1800.198-9%0.230-22%0.192-6%0.182-2%
Operating Margin--0.3470.215+62%0.287+21%0.273+27%0.262+33%
Operating Ratio--0.7080.844-16%0.715-1%1.002-29%1.038-32%
Pb Ratio6.091+12%5.3656.471-17%8.656-38%8.644-38%7.861-32%
Pe Ratio51.019+12%44.94247.132-5%58.580-23%48.471-7%60.852-26%
Price Per Share28.880+12%25.44028.560-11%31.975-20%27.494-7%23.150+10%
Price To Free Cash Flow Ratio42.907+12%37.79645.389-17%575.509-93%137.788-73%98.420-62%
Price To Total Gains Ratio103.564+12%91.228119.356-24%308.997-70%176.697-48%318.389-71%
Quick Ratio--1.2401.229+1%1.226+1%1.272-3%1.207+3%
Return On Assets--0.0190.021-8%0.026-25%0.021-9%0.020-4%
Return On Equity--0.0300.034-12%0.041-27%0.036-17%0.034-13%
Total Gains Per Share--0.2790.242+15%0.198+41%0.187+49%0.213+31%
Usd Book Value--4480349889.7984197251429.536+7%3489991365.697+28%3063585115.676+46%2754746411.026+63%
Usd Book Value Change Per Share--0.1480.125+18%0.099+49%0.089+66%0.108+36%
Usd Book Value Per Share--3.0372.848+7%2.371+28%2.081+46%1.869+62%
Usd Dividend Per Share--0.0310.029+4%0.028+11%0.031-1%0.028+9%
Usd Eps--0.0910.097-6%0.088+3%0.073+23%0.064+42%
Usd Free Cash Flow--158994669.600151091813.400+5%26998623.600+489%74659881.280+113%53328486.629+198%
Usd Free Cash Flow Per Share--0.1080.103+5%0.018+488%0.063+70%0.063+70%
Usd Free Cash Flow To Equity Per Share--0.0040.009-57%0.117-97%0.035-88%0.035-88%
Usd Market Cap27203745473.364+12%24037700899.20026961185739.536-11%30139417062.813-20%25914027471.781-7%21849014603.238+10%
Usd Price Per Share18.495+12%16.29218.290-11%20.477-20%17.607-7%14.825+10%
Usd Profit--133715520.000142550798.600-6%141604927.800-6%110488916.440+21%95740280.300+40%
Usd Revenue--744657760.400721102727.700+3%616235946.900+21%565891509.280+32%510571021.857+46%
Usd Total Gains Per Share--0.1790.155+15%0.127+41%0.120+49%0.137+31%
 EOD+4 -4MRQTTM+23 -12YOY+25 -105Y+23 -1210Y+28 -7

4.2. Fundamental Score

Let's check the fundamental score of Resmed Inc DRC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1551.019
Price to Book Ratio (EOD)Between0-16.091
Net Profit Margin (MRQ)Greater than00.180
Operating Margin (MRQ)Greater than00.347
Quick Ratio (MRQ)Greater than11.240
Current Ratio (MRQ)Greater than13.112
Debt to Asset Ratio (MRQ)Less than10.351
Debt to Equity Ratio (MRQ)Less than10.541
Return on Equity (MRQ)Greater than0.150.030
Return on Assets (MRQ)Greater than0.050.019
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Resmed Inc DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.412
Ma 20Greater thanMa 5029.148
Ma 50Greater thanMa 10028.530
Ma 100Greater thanMa 20027.144
OpenGreater thanClose28.810
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets6,905,088
Total Liabilities2,423,234
Total Stockholder Equity4,481,854
 As reported
Total Liabilities 2,423,234
Total Stockholder Equity+ 4,481,854
Total Assets = 6,905,088

Assets

Total Assets6,905,088
Total Current Assets2,378,077
Long-term Assets4,527,011
Total Current Assets
Cash And Cash Equivalents 210,247
Short-term Investments 7,617
Net Receivables 729,740
Inventory 933,214
Other Current Assets 179,632
Total Current Assets  (as reported)2,378,077
Total Current Assets  (calculated)2,060,450
+/- 317,627
Long-term Assets
Property Plant Equipment 705,207
Goodwill 2,861,854
Intangible Assets 528,178
Long-term Assets Other 134,736
Long-term Assets  (as reported)4,527,011
Long-term Assets  (calculated)4,229,975
+/- 297,036

Liabilities & Shareholders' Equity

Total Current Liabilities764,073
Long-term Liabilities1,659,161
Total Stockholder Equity4,481,854
Total Current Liabilities
Short-term Debt 33,955
Short Long Term Debt 9,898
Accounts payable 202,395
Other Current Liabilities 378,826
Total Current Liabilities  (as reported)764,073
Total Current Liabilities  (calculated)625,074
+/- 138,999
Long-term Liabilities
Long term Debt 1,216,769
Capital Lease Obligations 164,706
Long-term Liabilities Other 72,894
Long-term Liabilities  (as reported)1,659,161
Long-term Liabilities  (calculated)1,454,369
+/- 204,792
Total Stockholder Equity
Common Stock588
Retained Earnings 4,539,963
Accumulated Other Comprehensive Income -208,352
Other Stockholders Equity 149,655
Total Stockholder Equity (as reported)4,481,854
Total Stockholder Equity (calculated)4,481,854
+/-0
Other
Capital Stock588
Cash and Short Term Investments 210,247
Common Stock Shares Outstanding 1,475,450
Current Deferred Revenue148,897
Liabilities and Stockholders Equity 6,905,088
Net Debt 1,181,126
Net Invested Capital 5,708,521
Net Working Capital 1,614,004
Property Plant and Equipment Gross 1,419,579
Short Long Term Debt Total 1,391,373



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
3,422,563
3,468,487
3,489,617
3,564,000
3,534,208
3,063,923
3,067,538
3,859,816
4,098,526
4,107,682
4,154,558
4,353,939
4,510,543
4,587,376
4,620,844
4,572,856
4,585,724
4,728,125
4,729,167
4,734,742
5,095,853
5,177,560
5,177,560
6,676,104
6,713,879
6,751,708
6,740,786
6,905,088
6,905,0886,740,7866,751,7086,713,8796,676,1045,177,5605,177,5605,095,8534,734,7424,729,1674,728,1254,585,7244,572,8564,620,8444,587,3764,510,5434,353,9394,154,5584,107,6824,098,5263,859,8163,067,5383,063,9233,534,2083,564,0003,489,6173,468,4873,422,563
   > Total Current Assets 
1,605,361
1,644,003
1,657,946
1,754,349
1,604,406
1,065,717
1,088,243
1,063,539
1,102,696
1,145,366
1,161,098
1,300,485
1,469,758
1,523,459
1,542,609
1,451,485
1,466,150
1,574,757
1,586,255
1,547,240
1,931,478
2,033,697
2,033,697
2,325,156
2,337,815
2,367,830
2,304,585
2,378,077
2,378,0772,304,5852,367,8302,337,8152,325,1562,033,6972,033,6971,931,4781,547,2401,586,2551,574,7571,466,1501,451,4851,542,6091,523,4591,469,7581,300,4851,161,0981,145,3661,102,6961,063,5391,088,2431,065,7171,604,4061,754,3491,657,9461,644,0031,605,361
       Cash And Cash Equivalents 
827,310
821,935
811,102
858,899
704,281
188,701
230,188
149,468
146,513
147,128
172,154
204,095
352,861
463,156
421,414
255,865
230,635
295,278
276,149
194,476
273,710
207,163
207,163
253,199
227,894
227,891
209,100
210,247
210,247209,100227,891227,894253,199207,163207,163273,710194,476276,149295,278230,635255,865421,414463,156352,861204,095172,154147,128146,513149,468230,188188,701704,281858,899811,102821,935827,310
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,821
0
0
12,115
12,423
0
7,617
7,617012,42312,1150011,821000000000000000000000
       Net Receivables 
413,612
450,530
431,354
482,934
498,425
483,681
476,604
490,815
511,403
538,318
502,408
535,831
563,404
484,095
474,478
518,817
537,554
625,185
601,353
550,719
575,950
620,483
620,483
672,271
686,264
704,909
725,589
729,740
729,740725,589704,909686,264672,271620,483620,483575,950550,719601,353625,185537,554518,817474,478484,095563,404535,831502,408538,318511,403490,815476,604483,681498,425482,934431,354450,530413,612
       Inventory 
259,870
268,319
300,472
296,062
288,703
268,701
282,555
296,511
319,930
349,641
357,033
377,784
358,772
416,915
478,006
474,821
484,061
457,033
506,644
592,146
743,910
864,852
864,852
988,955
1,011,269
998,012
958,233
933,214
933,214958,233998,0121,011,269988,955864,852864,852743,910592,146506,644457,033484,061474,821478,006416,915358,772377,784357,033349,641319,930296,511282,555268,701288,703296,062300,472268,319259,870
       Other Current Assets 
104,569
2,614
4,146
9,687
980
281
1,299
0
0
371
0
0
0
0
0
0
0
72,409
77,826
89,229
337,908
341,199
341,199
410,731
412,388
437,018
444,864
179,632
179,632444,864437,018412,388410,731341,199341,199337,90889,22977,82672,4090000000371001,2992819809,6874,1462,614104,569
   > Long-term Assets 
0
0
0
0
0
0
0
0
2,995,830
2,962,316
2,993,460
3,053,454
3,040,785
3,063,917
3,078,235
3,121,371
3,119,574
3,153,368
3,142,912
3,187,502
3,164,375
3,143,863
3,143,863
4,350,948
4,376,064
4,383,878
4,436,201
4,527,011
4,527,0114,436,2014,383,8784,376,0644,350,9483,143,8633,143,8633,164,3753,187,5023,142,9123,153,3683,119,5743,121,3713,078,2353,063,9173,040,7853,053,4542,993,4602,962,3162,995,83000000000
       Property Plant Equipment 
387,412
394,241
400,795
401,537
397,981
386,550
381,822
381,505
382,496
387,460
464,620
505,109
523,486
535,683
549,292
590,763
583,861
592,065
601,719
623,823
630,495
612,695
612,695
650,967
656,286
665,811
657,401
705,207
705,207657,401665,811656,286650,967612,695612,695630,495623,823601,719592,065583,861590,763549,292535,683523,486505,109464,620387,460382,496381,505381,822386,550397,981401,537400,795394,241387,412
       Goodwill 
1,050,083
1,064,874
1,072,298
1,075,315
1,080,948
1,068,944
1,192,030
1,759,045
1,939,136
1,856,449
1,856,427
1,870,647
1,884,458
1,890,324
1,899,743
1,910,492
1,925,991
1,927,901
1,922,037
1,951,459
1,936,442
1,938,843
1,938,843
2,767,179
2,783,624
2,770,299
2,812,142
2,861,854
2,861,8542,812,1422,770,2992,783,6242,767,1791,938,8431,938,8431,936,4421,951,4591,922,0371,927,9011,925,9911,910,4921,899,7431,890,3241,884,4581,870,6471,856,4271,856,4491,939,1361,759,0451,192,0301,068,9441,080,9481,075,3151,072,2981,064,8741,050,083
       Long Term Investments 
39,691
38,324
40,600
39,795
41,149
41,226
41,982
62,859
49,146
52,100
45,391
54,739
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000054,73945,39152,10049,14662,85941,98241,22641,14939,79540,60038,32439,691
       Intangible Assets 
267,404
261,800
251,025
240,027
228,223
215,184
242,193
484,926
516,450
521,950
496,847
480,861
464,963
448,168
432,894
412,998
409,559
2,320,483
2,297,437
372,013
345,944
338,151
338,151
586,857
569,678
552,341
563,278
528,178
528,178563,278552,341569,678586,857338,151338,151345,944372,0132,297,4372,320,483409,559412,998432,894448,168464,963480,861496,847521,950516,450484,926242,193215,184228,223240,027251,025261,800267,404
       Long-term Assets Other 
0
0
0
0
0
0
0
0
2,995,830
2,962,316
2,993,460
3,053,454
3,040,785
0
0
0
0
0
0
0
251,494
254,174
254,174
691,890
366,476
395,427
265,109
134,736
134,736265,109395,427366,476691,890254,174254,174251,49400000003,040,7853,053,4542,993,4602,962,3162,995,83000000000
> Total Liabilities 
1,567,607
1,508,221
1,440,089
1,544,472
1,467,244
1,004,943
1,167,282
1,903,772
2,077,197
2,035,489
2,037,307
2,095,833
2,254,112
2,090,349
1,941,984
1,707,872
1,876,490
1,842,446
1,703,118
1,588,907
1,735,102
1,744,673
1,744,673
2,937,977
2,781,370
2,621,805
2,490,410
2,423,234
2,423,2342,490,4102,621,8052,781,3702,937,9771,744,6731,744,6731,735,1021,588,9071,703,1181,842,4461,876,4901,707,8721,941,9842,090,3492,254,1122,095,8332,037,3072,035,4892,077,1971,903,7721,167,2821,004,9431,467,2441,544,4721,440,0891,508,2211,567,607
   > Total Current Liabilities 
336,278
360,126
351,585
1,356,411
461,460
511,249
421,108
436,443
462,969
555,991
550,457
500,045
551,519
602,761
590,853
577,335
876,541
911,766
624,158
621,064
689,299
692,659
692,659
732,714
761,691
758,533
770,802
764,073
764,073770,802758,533761,691732,714692,659692,659689,299621,064624,158911,766876,541577,335590,853602,761551,519500,045550,457555,991462,969436,443421,108511,249461,4601,356,411351,585360,126336,278
       Short-term Debt 
1,168,917
1,078,611
1,018,871
1,019,132
810,000
11,466
11,975
11,978
12,346
11,992
11,992
11,984
0
0
0
0
0
0
0
0
31,772
30,982
30,982
32,329
33,030
31,821
0
33,955
33,955031,82133,03032,32930,98230,98231,7720000000011,98411,99211,99212,34611,97811,97511,466810,0001,019,1321,018,8711,078,6111,168,917
       Short Long Term Debt 
1,168,917
1,078,611
1,018,871
1,019,132
810,000
11,466
11,975
11,978
12,346
11,992
11,992
11,984
11,987
11,987
11,988
11,988
11,990
12,000
12,000
12,000
11,967
9,916
9,906
9,900
9,901
9,902
9,905
9,898
9,8989,9059,9029,9019,9009,9069,91611,96712,00012,00012,00011,99011,98811,98811,98711,98711,98411,99211,99212,34611,97811,97511,466810,0001,019,1321,018,8711,078,6111,168,917
       Accounts payable 
287,596
92,763
85,082
78,351
88,157
92,723
98,709
110,335
124,466
115,725
109,742
114,322
116,148
135,786
117,589
122,166
117,222
138,008
173,696
163,369
159,245
181,485
181,485
196,003
161,896
150,756
177,048
202,395
202,395177,048150,756161,896196,003181,485181,485159,245163,369173,696138,008117,222122,166117,589135,786116,148114,322109,742115,725124,466110,33598,70992,72388,15778,35185,08292,763287,596
       Other Current Liabilities 
48,682
119,805
113,439
92,315
208,285
246,637
162,888
143,516
156,007
244
199,831
159,981
189,386
195,078
201,079
175,173
451,003
447,769
172,497
165,560
389,615
371,997
743,994
370,473
425,722
437,884
0
378,826
378,8260437,884425,722370,473743,994371,997389,615165,560172,497447,769451,003175,173201,079195,078189,386159,981199,831244156,007143,516162,888246,637208,28592,315113,439119,80548,682
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
1,614,228
1,479,498
1,486,850
1,595,788
1,702,593
1,487,588
1,351,131
1,130,537
999,949
930,680
1,078,960
967,843
1,045,803
1,052,014
1,052,014
2,205,263
2,019,679
1,863,272
1,719,608
1,659,161
1,659,1611,719,6081,863,2722,019,6792,205,2631,052,0141,052,0141,045,803967,8431,078,960930,680999,9491,130,5371,351,1311,487,5881,702,5931,595,7881,486,8501,479,4981,614,22800000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
1,258,861
1,208,210
1,287,509
1,364,849
1,164,133
1,044,435
813,732
719,046
643,351
793,668
667,979
668,735
765,325
785,436
1,790,689
1,575,963
1,431,234
1,351,511
0
01,351,5111,431,2341,575,9631,790,689785,436765,325668,735667,979793,668643,351719,046813,7321,044,4351,164,1331,364,8491,287,5091,208,2101,258,861000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
85,386
99,496
130,046
123,143
132,512
140,086
137,765
138,364
144,437
156,882
151,384
142,309
135,290
138,874
138,219
138,772
134,243
164,706
164,706134,243138,772138,219138,874135,290142,309151,384156,882144,437138,364137,765140,086132,512123,143130,04699,49685,3860000000000
       Other Liabilities 
856
69,484
69,633
188,061
195,784
223,706
228,537
281,829
290,879
220,637
212,802
228,821
230,493
221,575
195,513
199,164
165,637
172,550
163,774
166,894
163,206
160,025
152,364
298,129
0
315,185
0
0
00315,1850298,129152,364160,025163,206166,894163,774172,550165,637199,164195,513221,575230,493228,821212,802220,637290,879281,829228,537223,706195,784188,06169,63369,484856
> Total Stockholder Equity
1,854,956
1,960,266
2,049,528
2,019,528
2,066,964
2,058,980
1,900,256
1,956,044
2,021,329
2,072,193
2,117,251
2,258,106
2,256,431
2,497,027
2,678,860
2,864,984
2,709,234
2,885,679
3,026,049
3,145,835
3,360,751
3,432,887
3,432,887
3,738,127
3,932,509
4,129,903
4,250,376
4,481,854
4,481,8544,250,3764,129,9033,932,5093,738,1273,432,8873,432,8873,360,7513,145,8353,026,0492,885,6792,709,2342,864,9842,678,8602,497,0272,256,4312,258,1062,117,2512,072,1932,021,3291,956,0441,900,2562,058,9802,066,9642,019,5282,049,5281,960,2661,854,956
   Common Stock
567
569
569
572
571
571
570
573
573
575
575
578
579
580
580
582
582
583
583
585
586
586
586
588
588
588
588
588
588588588588588586586586585583583582582580580579578575575573573570571571572569569567
   Retained Earnings 
2,261,425
2,316,237
2,352,664
2,312,335
2,372,487
2,432,328
2,296,473
2,368,339
2,420,731
2,436,410
2,500,506
2,604,910
2,711,639
2,832,991
2,953,709
3,076,569
2,941,336
3,079,640
3,222,064
3,362,570
3,613,736
3,759,783
3,759,783
3,920,197
4,088,057
4,253,016
4,401,841
4,539,963
4,539,9634,401,8414,253,0164,088,0573,920,1973,759,7833,759,7833,613,7363,362,5703,222,0643,079,6402,941,3363,076,5692,953,7092,832,9912,711,6392,604,9102,500,5062,436,4102,420,7312,368,3392,296,4732,432,3282,372,4872,312,3352,352,6642,316,2372,261,425
   Capital Surplus 
0
0
0
0
0
0
0
0
0
1,511,473
1,530,011
1,521,992
1,533,905
1,570,694
1,588,018
1,574,240
1,586,545
1,622,199
1,643,661
1,629,031
1,645,453
1,682,432
1,701,902
1,710,766
1,728,997
1,772,083
1,791,351
0
01,791,3511,772,0831,728,9971,710,7661,701,9021,682,4321,645,4531,629,0311,643,6611,622,1991,586,5451,574,2401,588,0181,570,6941,533,9051,521,9921,530,0111,511,473000000000
   Treasury Stock00000000-1,623,256-1,623,256-1,623,256-1,623,256-1,623,256-1,623,256-1,623,256-1,623,256-1,623,256-1,623,256-1,623,256000000000
   Other Stockholders Equity 
-213,101
-189,059
-152,670
-148,220
-155,613
-224,328
-237,200
-250,317
-252,818
-253,009
-290,585
-246,118
-366,436
-283,982
-240,191
-163,151
-195,973
-193,487
-217,003
-223,095
59,176
78,646
78,646
87,510
105,741
148,827
-320,148
149,655
149,655-320,148148,827105,74187,51078,64678,64659,176-223,095-217,003-193,487-195,973-163,151-240,191-283,982-366,436-246,118-290,585-253,009-252,818-250,317-237,200-224,328-155,613-148,220-152,670-189,059-213,101



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue4,222,993
Cost of Revenue-1,867,331
Gross Profit2,355,6622,355,662
 
Operating Income (+$)
Gross Profit2,355,662
Operating Expense-1,203,665
Operating Income1,131,8711,151,997
 
Operating Expense (+$)
Research Development287,642
Selling General Administrative874,003
Selling And Marketing Expenses-
Operating Expense1,203,6651,161,645
 
Net Interest Income (+$)
Interest Income44,722
Interest Expense--
Other Finance Cost-92,101
Net Interest Income-47,379
 
Pretax Income (+$)
Operating Income1,131,871
Net Interest Income-47,379
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,101,6641,134,825
EBIT - interestExpense = 1,141,974
1,101,664
897,556
Interest Expense-
Earnings Before Interest and Taxes (EBIT)1,141,9741,101,664
Earnings Before Interest and Taxes (EBITDA)1,339,536
 
After tax Income (+$)
Income Before Tax1,101,664
Tax Provision-204,108
Net Income From Continuing Ops897,556897,556
Net Income897,556
Net Income Applicable To Common Shares897,556
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses3,070,996
Total Other Income/Expenses Net-2,95447,379
 

Technical Analysis of Resmed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Resmed. The general trend of Resmed is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Resmed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Resmed Inc DRC.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 30.21 < 30.59 < 30.81.

The bearish price targets are: 28.42 > 28.01 > 26.64.

Tweet this
Resmed Inc DRC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Resmed Inc DRC. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Resmed Inc DRC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Resmed Inc DRC. The current macd is 0.10185046.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Resmed price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Resmed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Resmed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Resmed Inc DRC Daily Moving Average Convergence/Divergence (MACD) ChartResmed Inc DRC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Resmed Inc DRC. The current adx is 12.68.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Resmed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Resmed Inc DRC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Resmed Inc DRC. The current sar is 29.61.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Resmed Inc DRC Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Resmed Inc DRC. The current rsi is 50.41. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Resmed Inc DRC Daily Relative Strength Index (RSI) ChartResmed Inc DRC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Resmed Inc DRC. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Resmed price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Resmed Inc DRC Daily Stochastic Oscillator ChartResmed Inc DRC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Resmed Inc DRC. The current cci is -39.4234816.

Resmed Inc DRC Daily Commodity Channel Index (CCI) ChartResmed Inc DRC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Resmed Inc DRC. The current cmo is -2.66106989.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Resmed Inc DRC Daily Chande Momentum Oscillator (CMO) ChartResmed Inc DRC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Resmed Inc DRC. The current willr is -60.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Resmed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Resmed Inc DRC Daily Williams %R ChartResmed Inc DRC Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Resmed Inc DRC.

Resmed Inc DRC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Resmed Inc DRC. The current atr is 0.54607058.

Resmed Inc DRC Daily Average True Range (ATR) ChartResmed Inc DRC Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Resmed Inc DRC. The current obv is -21,187,032.

Resmed Inc DRC Daily On-Balance Volume (OBV) ChartResmed Inc DRC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Resmed Inc DRC. The current mfi is 44.12.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Resmed Inc DRC Daily Money Flow Index (MFI) ChartResmed Inc DRC Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Resmed Inc DRC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Resmed Inc DRC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Resmed Inc DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.412
Ma 20Greater thanMa 5029.148
Ma 50Greater thanMa 10028.530
Ma 100Greater thanMa 20027.144
OpenGreater thanClose28.810
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Resmed with someone you think should read this too:
  • Are you bullish or bearish on Resmed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Resmed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Resmed Inc DRC

I send you an email if I find something interesting about Resmed Inc DRC.


Comments

How you think about this?

Leave a comment

Stay informed about Resmed Inc DRC.

Receive notifications about Resmed Inc DRC in your mailbox!